The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

BTOG 2021 | Impacts of COVID-19 on lung cancer diagnosis in the UK

Name: Impacts of COVID-19 on lung cancer diagnosis in the UK
Uploaded: 2021-04-23T00:00:00Z
Duration: 2 min 58 s
Description: Riyaz Shah, FRCP, PhD, Maidstone and Tunbridge Wells NHS Trust, Kent, UK, shares his highlights from BTOG 2021, in particular talking on data from studies investigating the diagnostic pathway for lung cancer during the COVID-19 pandemic, including the impacts on time to diagnosis and staging. This interview took place during the 19th British Thoracic Oncology Group (BTOG) Annual Conference 2021.

Riyaz Shah • 23 Apr 2021

BTOG 2021

Lung Cancer

Riyaz Shah, FRCP, PhD, Maidstone and Tunbridge Wells NHS Trust, Kent, UK, shares his highlights from BTOG 2021, in particular talking on data from studies investigating the diagnostic pathway for lung cancer during the COVID-19 pandemic, including the impacts on time to diagnosis and staging. This interview took place during the 19th British Thoracic Oncology Group (BTOG) Annual Conference 2021.